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INRODUCTION
Since the ionizing radiation emitted during the Chernobyl nuclear accident, various disorders have been reported in humans living nearby, including thyroid cancer, 1) leukemia 2) and other non-cancerous diseases, such as cataracts, 3) atherosclerosis, 4) abnormal cardiac features 5) and other metabolic disturbances. 6) However, chronic low-dose contamination by local foodstuff did not clearly lead to observations of specific diseases with the exception of cardiovascular symptoms. 5) Experimental studies in rats chronically contaminated by 137 Cs, which is the most persistent radionuclide dispersed in this area (half-life of 30 years), have showed molecular and physiological effects in different metabolic pathways without, however, any major homeostatic deregulation. [7] [8] [9] [10] Currently, analytical sensitivity is increasing with the use of new noninvasive methods. One of these is metabolomics, which appears useful 11) for finding specific biomarkers of chronic radiocesium exposure. Metabolomics is the global profiling and quantitative characterization of metabolic phenotypes, i.e., small molecules (< 1000 g/mol), in biofluids, cells, tissues, organs and organisms under specific sets of conditions, such as environmental or radiation exposures. 12) Already used for drug toxicity modeling, 13) metabolomics is sufficiently sensitive to guide human health choices. 14, 15) Moreover, noninvasive quantitative or qualitative profiling could provide useful diagnoses in cases of radiological accidents, nuclear terrorism or radiotherapy oncology treatment. 16) The aim of the present study was to evaluate the effects *Corresponding author: Phone: +33158359194, Fax: +33158358467, E-mail: maamar.souidi@irsn.fr 1 of radiocesium exposure on rat health with multiple tests usually used in toxicology. To mimic the environmental contamination following the Chernobyl accident, especially among children, known to be a sensitive subgroup in toxicology 17, 18) and radiobiology, 19) rats were exposed to 137 Cs through drinking water from conception. 20) Consumption of food and drinking water were measured during the contamination protocol to monitor dietary behavior. Body weight and that of the main organs 21) were checked to evaluate any morphological or other possible specific effects. Blood cells were counted 22) and plasma metabolites measured to establish a 137 Cs toxicological diagnosis. Moreover, a mass-spectrometry-based metabolomic profile of rat plasma and urine, followed by a multivariate analysis, identified a specific metabolomic signature of low-level 137 Cs contamination.
MATERIALS AND METHODS

Animals
Male and female Sprague-Dawley rats, aged 12 weeks and weighing 274 ± 2 g, were obtained from Charles River Laboratories (L'Arbresle, France). They were housed in pairs (male and female separated) upon arrival and allowed to recover from transportation for 2 weeks before the first day of contamination. During the experiment, they were maintained in a 12-h light/12-h dark cycle (regular cycle) at 21 ± 2°C and 50 ± 10% humidity, with access to a standard pellet rodent diet and water ad libitum. For the experiment, the rats were divided into two groups per sex, control and 137 Cs-exposed. A week after contamination began; male rats were mated with females for 48 h (1 male with 2 females in each group). After weaning, male offspring were housed in pairs from different mothers (assigned by randomization). Female offspring and mothers were euthanized. All experimental procedures were approved by the Animal Care Committee of the Institute of Radioprotection and Nuclear Safety (IRSN) and complied with French regulations for animal experimentation (Ministry of Agriculture Act No. 87-848, October 19, 1987 , modified May 20, 2001 ).
Contamination procedure
Rats were contaminated with 137 cesium chloride ( 137 CsCl, CAS number 20334-19-4) obtained from CERCA (Pierrelatte, France). Parents of the offspring experimental group were exposed to 137 CsCl added to drinking water at a concentration of 6500 Bq/L (ca. 170 Bq/rat/day) a week before mating until euthanasia. This 137 Cs concentration corresponded to the maximum concentrations measured in milk in Belarus immediately after the Chernobyl accident. 23) Other study performed on the daily 137 Cs intake indicated a similar value (around 100 Bq) for inhabitants from Christinovska (Ukraine) that is included in the greatly contaminated zone II (between 555 and 1,480 kBq m -2 ). 24) The control rats received uncontaminated mineral water. The food and water intake of both groups was monitored weekly throughout the contamination period. During pregnancy, offspring were theoretically contaminated by mother's blood and subsequently by mother's milk until weaning (receiving approximately 20% of the mother's daily dose). 25) Weaned males were exposed to 137 CsCl in their drinking water at a concentration of 6500 Bq/L until they were 9 months old.
Measurement of 137
Cs organ contamination
Radiocesium activity was measured in organs with a gamma counter (Cobra Perkin Elmer, Cobra gamma counter with a NaI detector, Packard Instruments, Courtaboeuf, France) as described previously.
26) The detection limit (DL) was calculated with the following formula (CTHIR, French GTN5): 27) , where B is the background, obtained by averaging counts from 10 empty tubes, in counts per minute (cpm), and T is the duration of the counting period. The detection limit ranged from 4.2 to 12 counts per minute per sample, depending on the mass of the organ tested and on the duration of the counting period.
Dose calculation
The number of nuclear transformations in organs was estimated from 137Cs tissue measurements at 1, 3, and 9 months after the experiment started. To obtain a maximizing approximation, the activity in each tissue was assumed to be constant during the previous contamination period. The fraction of energy emitted from source tissue and absorbed in target tissue (AF) is taken from the voxel-based rat model designed by Stabin and co-workers. 28) Specific absorbed fractions were obtained by dividing AF by the tissue mass measured in the experiment and were convolved with the 137Cs and 137mBa emission spectra (International Commission on Radiological Protection 2008 Nuclear Decay Data for Dosimetric Calculations 29) ) to derive specific effective energies (SEEs). Multiplying the SEEs by the number of nuclear transformations in the source tissues yielded the absorbed doses in the target tissue.
Collection of organs and biofluids
When rats were 9 months old, their urine was collected for 48 h. They were placed in metabolic cages (one per cage) in the morning with access to a ground pellet rodent diet and water (contaminated or not) ad libitum. Urine was collected twice a day, with sodium azide (0.01%) 30) added to prevent bacterial growth, and refrigerated at +4°C. Each rat's fractions were pooled, mixed, and centrifuged; supernatants were frozen at -80°C. The rats were then moved to conventional cages (one per cage) with food and drink ad libitum
until the evening to reduce stress. To control the diet cycle, food was removed in the evening until the next morning. Five hours before euthanasia, around 12 g of standard pellet rodent food was added directly to each cage to stimulate the desire to eat before sleep. Rats were anesthetized by inhalation of 5% isoflurane (Abbot France, Rungis, France) and euthanized by intracardiac puncture to collect blood in heparinized tubes. Whole blood was centrifuged (5000 rpm) and plasma supernatants were immediately frozen at -80°C. Organs were dissected on ice, weighed, deep-frozen in liquid nitrogen and stored at -80°C.
Blood cell counts
Complete blood counts (CBC) were measured by a MS-9 vet automatic counter (Melet-Schlossing, Osny, France). Remaining blood was centrifuged at 400 g for 10 min, and plasma was frozen (-80°C) for later use.
Biochemical panel
Biochemical measurements were taken from defrosted plasma samples by an automated spectrometric system (Konelab 20 from Thermo Electron Corporation, CergyPontoise, France), with the manufacturer's biological chemistry reagents. The markers measured in plasma included glucose, albumin, total protein, lactate dehydrogenase (LDH), alkaline phosphatase (ALP), cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, phospholipids, triglycerides, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), triglycerides, total bilirubin, transferrin, iron, phosphorus, calcium, chlorine, potassium, magnesium, urea, creatinine and creatine kinase.
Urine and plasma sample preparation for metabolomic analysis
Plasma was thawed before either methanolic protein precipitation (to extract polar compounds) or organic solvent extraction (non-polar compounds). To extract polar compounds, 200 μL of plasma was mixed for 10 seconds with a double volume of methanol. The mixture was centrifuged at 13 000 rpm for 10 min (at +4°C). An equal volume of methanolic supernatant was taken from all tubes, evaporated under a nitrogen flow, and finally stored at -80°C until analysis. Before analysis, dry extracts were resolubilized with 100 μL of H2O containing 0.1% formic acid for positive electrospray ionization (ESI+). Urine samples were centrifuged at 13 000 rpm for 10 min and then were diluted with water 350/1050 μL. Mixtures were centrifuged at 3000 rpm for 5 min and then placed in the liquid chromatography coupled to mass spectrometry (LC-MS) autosampler (at +4°C). Non-polar compounds were extracted with Bligh and Dyer's method: 200 μL of plasma was added to 200 μL of saline and 400 μL of methanol. The mixture was vigorously shaken for 30 s; 400 μL of chloroform was then added and mixed. After centrifugation (2000 g for 10 min at 4°C), the lower phase was taken with a Pasteur pipette and filtered on Na 2 SO 4 . The supernatant was re-extracted with 400 μL of chloroform, and the lower phases were assembled and dried under a nitrogen stream. Extracts were stored under a nitrogen atmosphere at -80°C until analysis. Before LC-MS processing, the samples were reconstituted with 1 mL acetonitrile-isopropanol mixture (5:2, v/v), 0.1% of formic acid and 1% of ammonium acetate.
LC-MS analysis
The samples were analyzed on an Agilent 1200 RRLC coupled to a Brüker microTOF ESI-hybrid quadrupole-time of flight mass spectrometer (Wissembourg, France). For the non-polar compounds (non-polar plasma), the liquid chromatographic conditions were: autosampler set at 15°C; column EC 100/2 Nucleodur C18 Isis, particle size 1.8 μm (Isis1) (Macherey-Nagel, Les Ulis, France). Solvent A: water + 0.1% formic acid + 0.1% ammonium acetate 1 M; solvent B: acetonitrile-isopropanol (5:2, v/v) + 0.1% formic acid + 1% ammonium acetate 1 M; eq with 60% B (40% A), 0-5 min 60-100% B, 5-10 min 100% B, 10-12 min 100-60% B, 12-15 min 60% B; flow 0.4 mL/min at 50°C. For polar compounds (plasma methanol extracts and urine), the liquid chromatographic conditions were: autosampler set at 4°C; column, EC 100/2 Nucleodur C18 pyramid, particle size 1.8 μm (Macherey-Nagel, Les Ulis, France); started from solvent A (95% water, 5% acetonitrile, 0.1% formic acid) to solvent B (95% acetonitrile, 5% water, 0.1% formic acid) from 0-10 min at 0.4 mL/min at 40°C column oven; thereafter switched to 95% A to 5% B for 6 min, held 2 min, and then returned to 100% A for 5 min.
The mass spectrometry (MS) conditions were as follows: full scan mode from m/z 50 to m/z 1500; capillary kV, 4.5; capillary temperature, 200°C; cone voltage at 40 V; drying gas flow set at 10 L.min-1 and nebulizing gas pressure (nitrogen) at 2.4 bar; positive electrospray ionization mode (ESI+).
Statistics
This animal protocol of 137 Cs contamination used two groups each of 20 rats. Each treatment group (control and contaminated) was divided in two subgroups (10 rats for the metabolomic study and 10 rats for other studies). The means of some measurements could be established for 10 to 20 individuals. Health diagnostic values were reported as means ± standard errors of the means (SEM). The control and contaminated groups were compared with Student's ttest in normal populations or the rank sum test in non-normal populations. Statistical significance was set at a p value less than 0.05. Statistical analyses were performed with Sigmastat statistical software (SPSS, Paris, France). Simca-P12 software (Umetrics, Umeå, Sweden) was used for all multivariate data analyses and modeling. Unsupervised hierarchi-cal clustering was performed with Permutmatrix (www. lirmm.fr/~caraux/PermutMatrix/). Figure 1 describes the workflow of the metabolomic data analysis. After deconvolution of the raw data with the LC/MS-based data analysis software (XCMS), 31) the data from the plasma polar and non-polar compounds and from urine compounds were merged, and several filtration methods were applied to ensure proper data quality (Fig. 1) . This reduced the number of variables to be analyzed per rat from 4139 to 600 (404 polar plasma, 185 non-polar plasma and 11 urine). Before multivariate analysis, the peak intensity values of the filtered data were scaled into units of variance. A principal component analysis of the pooled data with the quality control samples revealed that the analytical variance was satisfactory and lower than the biological variance. All the models evaluated were tested for overfitting, as described previously, with methods including permutation tests, cross-validation and cross validation-ANOVA.
15)
RESULTS
Cs activity in tissues and absorbed dose
137
Cs was measured in different organs (striated muscle, liver, kidney, brain, testicle, and biofluids) to check both the contamination level and homogeneity between the animals in each group (exposed versus control) ( Table 1) . Measurements showed that 137 Cs was incorporated into muscles at twice the rate as into other organs, which confirmed previous results. 32) Nonetheless, the high level of 137 Cs in urine demonstrated substantial intestinal absorption and urinary elimination of ingested radiocesium. The mean whole-body absorbed dose after 9 months of contamination was estimated at a maximum value of 4 mGy, under conservative assumptions for intermediate activity concentrations. Accordingly, this value can be considered to be the highest estimated dose received during the experiment.
In order to assess the magnitude of the overestimate induced by the conservative assumptions, a simple exponential model of 137 Cs whole body retention was fitted to the observed activity data. If the retention after an acute intake is where λ is the clearance rate and t the time after intake. The retention after a period t of chronic intake at a rate i may be expressed as
The number of nuclear transformations over this period is then the integral While, under the conservative assumptions, the retention is supposed to stay constant between two measurements at times t1 and t2: for t1 < t < t2 and The ingestion rate is approximately 170 Bq.d -1 . From the activities measured in organs, clearance rates of 0.8, 0.2 and 0.05 d -1 were estimated for rats of ages less than 3 weeks, from 3 weeks to 3 months and older than 3 months respectively. Comparing the number of nuclear transformations with such parameter values and the conservative assumptions yielded differences up to 8% over the duration of the experiment. It is therefore reasonable to assume the magnitude of the overestimate of the dose to be less than 10%. Fig. 1 . Workflow of the metabolomic data analysis. Table 1 . Mean 137 Cs radioactivity in different organs (Bq/g) in the rat after 9 months of chronic ingestion through drinking water (6500 Bq/L). DL: detection limit. Number of animals for each organ is indicated in parentheses. 
Dietary behavior
We monitored drinking water and food consumption for three weeks before the end of contamination (once a week) and found no difference in the diets of the control and treated groups (Table 2) .
Animals and organ weights
To identify any toxicological effect manifested morphologically, the whole body and principal organs were weighed, and the weights compared between the two groups. Calculation of absolute (Table 3 ) and relative weights (Table  4) showed no statistically significant effects.
Blood and plasma biochemistry panels
No imbalance in complete blood counts was observed after contamination (Table 5) .
To examine the animal's health, we tested a number of plasma biochemical levels, including proteins, minerals, liver, cardiovascular and kidney markers (Tables 6&7). Except for slightly elevated creatinine levels in the contaminated rats (P ≤ 0.05), within the physiological range, no differences were observed between groups.
Metabolic effects in plasma and urine
Overall, we analyzed 2053 metabolic features per rat, including 742 in urine, 368 non-polar and 941 polar in plasma.
Discriminant analysis was performed to examine whether the 137 Cs intake produced a metabolic shift that could distinguish the contaminated from the non-contaminated rats (Fig.  2) . The model including all the variables described the group variance with acceptable accuracy (R2Y = 0.46), but was not Table 2 . Mean dietary consumption was calculated for 3 weeks before euthanasia for each cage of two rats (mL/day/ rat for water and g/day/rat for food). The number of animals for water and food is indicated in brackets.
Water intake (20) Food consumption 
Alkaline phosphatase (U/L) 128 ± 15 153 ± 7 Table 3 . Mean ± SEM of whole-body and organ weight (g) in each group. Number of animals for each organ is indicated in parentheses.
Total body
Liver ( Cs (g) 548 ± 12 19,9 ± 0,2 1,49 ± 0,03 0,9 ± 0,1 1,67 ± 0,05 0,71 ± 0,02 1,99 ± 0,05 Table 4 . Mean ratios of organ to whole body weight (%) for each group. Number of animals for each organ is indicated in parentheses.
Liver ( Cs ingestion, we selected variables according to the PLS score contribution index (variable importance in projection, VIP). This procedure filtered out the variables that made no important contribution to class discrimination. After this selection, applying several thresholds of variable-importance-in-projection (VIP) with SIMCA software, the discriminant analysis model obtained 69
11,5 ± 0,6 11,4 ± 0,5 Triglycerides (mM) 1,5 ± 0,3 1,7 ± 0,2 Cholesterol (mM) 2,7 ± 0,2 2,7 ± 0,2 HDL-cholesterol (mM) 2,2 ± 0,2 2,1 ± 0, Cs. Control rats: from Ctrl1 to 10, 137 Cs treated rats, from 137 Cs1 to 9.
described 99% of the group variance, with a prediction index (Q2Y) of 0.867 (Fig. 2) Cs from the control non-treated rats (Fig. 3) . This discriminant analysis modeled 45.3% of the variation of the metabolic variables (R 2 X), but most importantly 81.1% of the treatment group's metabolic characteristics (R 2 Y) (prediction values Q 2 = 58.6% after cross-validation). With this combination of variables, the model assigned all the control rats to the non-contaminated group, and 88.9% of the 137 Cs-treated rats to the contaminated group (Fig. 4) . The statistical discrimination level obtained between the groups was significant (P = 0.01951 after crossvalidation ANOVA). We then challenged our class membership prediction model by the leave-one-out (LOO) technique, to predict class membership of the unassigned -left out -observation (an individual rat). For this validation, we took out one animal per group from the original dataset, thus leaving a training dataset. The rat taken out was then rein- troduced into this training set to assess whether the model could predict its class membership correctly. This test was performed for each rat. The error rate was determined by three different calculations: the misclassification table and the classification list of the SIMCA software, and a z-score calculated from the PLS t [1] scores obtained for each rat, from the intensity values of the metabolic variables ( Table  8 ). The error rate was very low and identical for each assessment method. Depending on the test used, the metabolic signature correctly assigned from 68 up to 94% of the rats to their treatment group (control or 137 Cs contaminated). One false positive (i.e., control rat positive for the metabolic response measured) was found, and one out of range (ultrasensitive to 137 Cs-treatment). Finally, to obtain more insights into the metabolic response observed in 137 Cs-exposed rats, the metabolic component values were analyzed by hierarchical clustering. This analysis produced 5 clusters according to the statistical proximity of the variables (Fig. 4A) . It is generally considered that this statistical proximity overlaps with co-regulated biological functions. Our attempt at structural elucidation identified some lipids (phospholipids, bile acids and sterol derivatives) and amino-acid breakdown derivatives (3-indolpropionic acid).
The results in Fig. 4A also indicated that the values for each variable did not always differ between the control and the 137 Cs-contaminated rats in univariate analyses, but the (multivariate) combined PLS metabolic scores, displayed as box-plots, differed significantly between the groups (Fig.  4B) .
DISCUSSION
Metabolomics is a new analytical technique that measures all of the small organic molecules (excluding proteins and nucleic acids) detectable in biological fluids. 33) Its particularity is its high detection sensitivity for metabolites when coupled with mass spectrometry, its relatively noninvasive nature, and the fast data processing, directly from plasma or urine samples. For these reasons, metabolomics could be particularly interesting as a new analytical approach that might enrich more standard methods commonly used in human clinical chemistry. Metabolomics is already applied in pharmaceutical applications for finding biomarkers, notably in drug toxicology to diagnose drug-induced effects or for therapeutic monitoring applications. 34) More recently, the use of high irradiation doses (> 10 Gy) in humans has created metabolomics applications in the domain of radiotherapy: the metabolic profile helps monitor response to treatment and simultaneously increases our knowledge of tumor pathophysiology. 35) Other experimental studies with more moderate gamma irradiation doses (between 3 to 8 Gy) found a metabolic dose-response relation in mouse urine 24 hours after irradiation. This analytical method may be adapted to noninvasive radiation biodosimetry in humans. 36) Moreover, urine has also been used to describe the course of a metabolic phenotype in rats after irradiation; it has showed effects on kidney functions following oxidative stress. 12) Other biological fluids, such as sebum, have also been explored as biomarker sources 37) in experiments demonstrating the diversity of potentially usable biofluids.
Nothing in the literature thus far describes the pertinence of metabolomic techniques in cases of radiotoxicity following chronic low doses of contamination by radionuclides. Nonetheless, the possibility of obtaining a specific metabolic fingerprint rapidly from accessible biofluids such as plasma or urine makes metabolomics a potentially original and relevant tool to diagnose and estimate the impact of environmental contamination, estimates that will be necessary for the medical management of populations in such cases 38, 39) or for developing appropriate public health recommendations.
The aim of this study was to find a new and more sensitive tool to evaluate the possibility of physiological changes caused by low-dose ingestion of 137 Cs. A few studies have described clearly non-cancerous health consequences to populations living in territory contaminated by the Chernobyl fallout. 3, 40, 41) The issue of direct health consequences of low levels of internal 137 Cs exposure is far from resolved. The high exposure effects of irradiation observed in the liquidators and the possible role of other pollutants, such as the strontium 90 dispersed in the area during the accident, 42) as well as mental health effects due to the nuclear trauma 43) and the degradation of living conditions in a disaster area 44) must all be considered. For that reason, beginning research in experimentally standardized conditions is likely to be a good initial approach. To mimic the radiological exposure in territories around Chernobyl, rats were chronically exposed to radiocesium in their drinking water. During the 9 months of exposure, animals received a maximal dose of irradiation (less than 4 mGy) lower than the annual limit recommended for radiation-exposed workers by the International Commission on Radiological Protection (ICRP n°103) 45) and slightly higher than the maximum public annual limit dose of 1 mSv/y, which is itself higher than the residual radiological dose that persists around Chernobyl. 46) The irradiation dose to these rats thus ranged between the environmental doses around Chernobyl and the acceptable limit for workers. Ingestion through drinking water in our experiment was estimated at about 0.7 ng cesium a day per rat. At this level, the quantity of dietary cesium metal intake is insignificant compared with the gamma-radiation activity. The weak organ irradiation is thus almost certainly the principal cause for possible biological effects. To determine those potential effects, we measured the standard clinical biomarkers and biometric variables during and after treatment in each experimental group to check their health status. Problems such as anorexia, weight loss 47) and visceral tissue damage were not found, although they have been described with stronger external gamma irradiation. 48) Also, our study did not show a body weight increase as described in case of higher cumulated irradiation (6 Gy) at low-dose rate in rodents exposed during the same duration (9 months). 49) Moreover, these results confirmed the very low-dose range (0.004 Gy) of our study, consistent with results of similar experimental protocols carried out earlier in rats. [7] [8] [9] [10] 50, 51) In addition, there was no imbalance in the proportions of blood cell types, such as that described in cases of high whole-body external irradiation (with a decrease white blood cells), 48, 52) nor did we observe a change between the groups in hepatic, heart or kidney enzyme activity in plasma. Similarly, plasma lipid, protein and mineral concentrations did not change; such a change might have revealed a dysfunction or rupture in the organ or tissue integrity.
Nonetheless, previous experimental studies in rats chronically exposed to 137 Cs showed some modifications of genes and molecules, particularly in liver cholesterol metabolism.
9,51) Molecular and hormonal modifications have been described in testicular steroidogenesis and adrenal steroidogenic metabolism.
7) Exposure appears to modify vitamin D metabolism and cause mineral imbalances. 10) Finally, studies of the cardiovascular system have shown few genic, plasmatic biomarker or physiological modifications. 8) Accordingly, in this dose range (up to less than 4 mGy), the lack of observable major health effects is not surprising because these experimental results have indicated no major disturbances of genes or molecules. On the other hand, biological responses in different metabolisms indicate the possibility of a physiological response at low levels of 137 Cs exposure. Overall, the metabolomic approach, which provides a simultaneous analysis of all detectable metabolites in urine and plasma, may also offer a systemic metabolic fingerprint that reflects physiological adjustments and describes the specific metabolic regulation pathways in cases of low exposure.
The results we obtained in this first application were very encouraging. Our untargeted metabolomic approach found a combination of 26 robust metabolic markers that together were sensitive to 137 Cs contamination. In this specific combination, most of the metabolites were polar plasma metabolites, while a few of them were non-polar lipids and urinary metabolites. Although not all the rats could be correctly assigned according to the treatment, most were distinguished as contaminated or not contaminated with an accuracy that ranged from 68% up to 94% according to the statistical evaluation. Thus, our proof of principle study, which examined the potential of the metabolomic approach for characterizing low-dose 137 Cs contamination, provided satisfactory and promising results. It was possible to discriminate controls from contaminated animals and to confirm the interest of this new global technique compared with standard univariate analytical methods. The next step is to confirm and validate our results with more information on the rat treatment conditions, such as time of treatment, dose gradient, and determination of the correct molecular structure of each metabolite.
Later on, after complementary investigations, it will be necessary to assess the concentration of each 137 Cs sensitive metabolite in a subset of well-defined contaminated and control individuals in sufficient numbers to serve as a reference population and yield optimal delineation. This assessment could be performed by quantitative mass-spectrometry, such as GC-MS or triple-quad LC-MS instruments, which might allow the assessment of a selection of discriminating metabolites based on multiple reaction monitoring (MRM). A composite score from the concentration values could then be calculated according to the algorithm used here. Suspicious unknown samples analyzed in the same way could then be assigned -or not -to the 137 Cs contamination group, based on comparison of their composite scores with those of reference samples. To increase our knowledge about metabolic interactions with 137 Cs, another further objective should be the molecular identification of variables that can be quantitatively modified in case of contamination. This identification requires comprehensive LC-MS-based data. Unfortunately the mass databases are not yet fully optimized and it is often necessary to use time-consuming methods to elucidate the full structure of metabolites. At this state of our study, a first search in mass databases has shown a strong presumption for steroid molecules (Fig. 4) , which is in accord with previous experimental results. 7, 9, 10, 50, 51) In conclusion, metabolomics, applied to chronic low-dose exposure to 137 Cs, has for the first time provided a significant and specific metabolic signature in a case in which standard clinic analysis yielded no information. Hence metabolomics appears to be a sufficiently sensitive analytical tool for use in cases of chronic low-dose radiological exposure. Metabolic signature profiles for any pollutant could be used to sort and follow populations living or working in exposed areas. Moreover, determination of the metabolites most affected will make it possible to evaluate biological changes associated with long-term health effects on populations exposed to accidents or chronic industrial dumping and will improve our knowledge of metabolism networks. It is now necessary to confirm the interest of metabolomics with other radionuclides, under other experimental conditions such as time of exposure and dose ranges, other biological conditions such as age, sex, stress, and other animal models, and in multi-pollution approaches. Such studies will show the relevance and specify the limitations of this new analytical technique in understanding the effects induced by chronic low-dose environmental exposures. Validation by methodological optimization remains necessary before its adoption for routine use.
